European Archives - Page 21 of 1462 - European Medical Journal

Epicardial fat index predicts HFpEF risk on MRI - EMJ

Epicardial Fat Index Predicts HFpEF Risk on MRI

Epicardial adipose tissue index on cardiac MRI may help identify high-risk HFpEF patients and predict heart failure readmission or death.

Bronchiectasis Insights: Understanding the Vicious Vortex

In this first instalment of Bronchiectasis Insights, Stuart Elborn and James Chalmers discuss the pathophysiology of bronchiectasis and…..

CAMCEVI® (leuprolide mesylate) 42 mg Injectable Emulsion: Ready-to-Use Innovation in Androgen Deprivation Therapy

Ready-to-Use Innovation in Androgen Deprivation Therapy

Androgen deprivation therapy (ADT) is essential in advanced prostate cancer but often requires complex, multi-step preparations…

Diabetes Shoulder: Near Fourfold Higher Risk of Adhesive Capsulitis

Patients with diabetes have a near fourfold higher risk of ‘frozen shoulder’, a new systematic review and meta-analysis has found.

Aspirin Cuts Cardiovascular Risk in Giant Cell Arteritis

Low-dose aspirin reduces cardiovascular risk in giant cell arteritis but increases bleeding risk, highlighting a complex clinical trade-off.

Explainable AI Predicts Parkinson’s Disease with 93% Accuracy

A new explainable AI framework improves Parkinson’s disease prediction accuracy while offering clinically interpretable insights for early diagnosis.

Sign with Novo Nordisk

Oral semaglutide shows promise in paediatric type 2 diabetes

A phase 3 trial has shown efficacy in type 2 diabetes for adolescents, positioning it as a potential first oral solution for this population.

EMJ Oncology 14 [Supplement 3] 2026

Three global experts, James Harding, Arndt Vogel, and Teresa Macarulla, share their insights on the evolving management of biliary tract…

A New Era for Biliary Tract Cancer

Content Under Review

Liquid Biopsy Shows Promise in High-Risk Localised Prostate Cancer

Liquid biopsy shows high success for genomic profiling in high-risk localised prostate cancer, outperforming tissue samples despite low ctDNA levels.